Rosuvastatin and Colchicine combined myotoxicity: Lessons to be learnt

N Sabanis, E Paschou, A Drylli, P Papanikolaou… - CEN Case Reports, 2021 - Springer
Statins and colchicine co-administration consists of a potentially catastrophic drug–drug
interaction since it provokes myotoxicity, myopathy and various degrees of rhabdomyolysis …

[HTML][HTML] Severe rhabdomyolysis associated with simvastatin and role of ciprofloxacin and amlodipine coadministration

N De Schryver, X Wittebole, P Van den Bergh… - Case reports in …, 2015 - hindawi.com
Simvastatin is among the most commonly used prescription medications for cholesterol
reduction and the most common statin-related adverse drug reaction is skeletal muscle …

Acute myopathy in a patient with concomitant use of pravastatin and colchicine

G Alayli, K Cengiz, F Cantürk… - Annals of …, 2005 - journals.sagepub.com
OBJECTIVE To report a case of acute myopathy after concomitant use of colchicine and
pravastatin. CASE SUMMARY A 65-year-old woman was admitted to the hospital with an …

Rapid onset of muscle weakness (rhabdomyolysis) associated with the combined use of simvastatin and colchicine

M Justiniano, S Dold, LR Espinoza - JCR: Journal of Clinical …, 2007 - journals.lww.com
We report a case of a patient with mild chronic renal insufficiency who had been taking
simvastatin for over a year and developed acute weakness within 3 weeks after the start of …

[HTML][HTML] Myopathy caused by the interaction of colchicine and statins

AS Kazakov, MA Darmostukova, TM Bukatina… - Safety and Risk of …, 2018 - risksafety.ru
Myopathy is a life-threatening disease that can be caused, among other things, by the intake
of various medications. Despite the fact that many drug-induced myopathies are well known …

Rosuvastatin-induced rhabdomyolysis: case report and call for proactive multifactorial risk assessment and preventive management of statin therapy in high-risk …

DF Niedrig, M Pyra, R Lussmann, A Serra… - European Journal of …, 2024 - ejhp.bmj.com
Cholesterol-lowering statins are frequently prescribed for primary and secondary prevention
of ischaemic vascular events. Whereas most patients tolerate statins without problems, statin …

[HTML][HTML] Colchicine triggered severe rhabdomyolysis after long-term low-dose simvastatin therapy: a case report

C Frydrychowicz, B Pasieka, M Pierer… - Journal of medical case …, 2017 - Springer
Background Rhabdomyolysis is a widely recognized yet rare complication in statin use.
Rhabdomyolysis might be triggered by the prescription of high doses of statins or by statin …

A systematic review of the drug–drug interaction between statins and colchicine: patient characteristics, etiologies, and clinical management strategies

NC Schwier, CK Cornelio… - … : The Journal of Human …, 2022 - Wiley Online Library
Colchicine and statins are frequently co‐prescribed for prevention and treatment of
cardiovascular diseases, auto‐inflammatory diseases, and gout. Both are substrates and …

Possible colchicine rhabdomyolysis in a fluvastatin-treated patient

EM Atasoyu, TR Evrenkaya… - Annals of …, 2005 - journals.sagepub.com
Discussion Two different mechanisms may be responsible for the pathogenesis in our
patient. Drug interactions that potentiate adverse effects may occur when colchicine is …

[HTML][HTML] High-intensity statin with severe consequences: a case of non-autoimmune rosuvastatin-induced myonecrosis

M Hassan, B Nguyen, K Helmsdoerfer, S Nadella… - Cureus, 2022 - ncbi.nlm.nih.gov
Statins constitute a cornerstone in the primary and secondary prevention of atherosclerotic
cardiovascular disease (ASCVD). The routine use of these lipid-lowering agents may lead to …